Textron Operating Cash Flow decreased by 116.7% to -$117.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from -$124.00M to -$117.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -4.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $181.00M | $591.00M | $401.00M | $425.00M | $241.00M | $372.00M | $348.00M | $527.00M | $163.00M | $296.00M | $258.00M | $549.00M | -$7.00M | $367.00M | $208.00M | $446.00M | -$124.00M | $387.00M | $349.00M | $700.00M | -$117.00M |
| QoQ Change | — | +226.5% | -32.1% | +6.0% | -43.3% | +54.4% | -6.5% | +51.4% | -69.1% | +81.6% | -12.8% | +112.8% | -101.3% | >999% | -43.3% | +114.4% | -127.8% | +412.1% | -9.8% | +100.6% | -116.7% |
| YoY Change | — | — | — | — | +33.1% | -37.1% | -13.2% | +24.0% | -32.4% | -20.4% | -25.9% | +4.2% | -104.3% | +24.0% | -19.4% | -18.8% | <-999% | +5.4% | +67.8% | +57.0% | +5.6% |